<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[smallcap Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/smallcap.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to smallcap]]></description>
	<s:counts start="0" returned="12" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[GeoEye: It's Make or Break Time]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90338-geoeye-it-s-make-or-break-time%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Chris Fernandez submits: Like one of its satellites racing overhead for some amazing and spectacular shots of the Earth, GeoEye (NASDAQ: GEOY) is getting ready to ramp up its own news stream with a flurry of activity over the next 10 days or so.  Not only is the company...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 11 Aug 2008 08:19:46 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/geoeye+inc..html"><![CDATA[GeoEye Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GEOY</category>
		<category domain="tickers">GEOY</category>
	</item>
	<item>
		<title><![CDATA[Six Market Beating Smallcaps to Own]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90337-six-market-beating-smallcaps-to-own%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Market Beating Stocks submits:  The market was up very strong last week, with oil again the big story. Oil prices dropped 7.9% last week and are now down 22% from mid July highs. The financial sector also showed gains last week despite negative press from several major firms. That...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 11 Aug 2008 08:05:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/industrial+services+of+america+inc..html"><![CDATA[Industrial Services of America Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mantech+international+corp..html"><![CDATA[ManTech International Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/nci+inc..html"><![CDATA[NCI Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nn+inc..html"><![CDATA[NN Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/olin+corp..html"><![CDATA[Olin Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/thermadyne+holdings+corp..html"><![CDATA[Thermadyne Holdings Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IDSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MANT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NCIT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NNBR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">THMD</category>
		<category domain="tickers">IDSA,MANT,NCIT,NNBR,OLN,THMD</category>
	</item>
	<item>
		<title><![CDATA[BioSante Pharma Announces Its Re-Acquisition of Elestrin]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90199-biosante-pharma-announces-its-re-acquisition-of-elestrin%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Last week, BioSante Pharma BPAX announced that it had reacquired Elestrin estradiol gel from privately-held Nycomed, which acquired the rights to the product along with its acquisition of Bradley Pharma in February 2008. BioSante will assume all manufacturing, distribution, and marketing responsibilities for Elestrin, which is a...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 10 Aug 2008 06:35:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/biosante+pharmaceutical+inc..html"><![CDATA[Biosante Pharmaceutical Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BPAX</category>
		<category domain="tickers">BPAX</category>
	</item>
	<item>
		<title><![CDATA[VSE Corporation: Another Look at Valuation]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90178-vse-corporation-another-look-at-valuation%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Robert Blumenthal submits:  In my recent valuation of VSE Corporation VSEC, I suggested waiting for the price, which is currently around $40, to pull back to the range $33-$35. However, I have decided to pick up a few more shares at the current price based on what I believe...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 10 Aug 2008 04:28:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/vse+corp..html"><![CDATA[VSE Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VSEC</category>
		<category domain="tickers">VSEC</category>
	</item>
	<item>
		<title><![CDATA[Winning Investment Style in a Bear Market]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89973-winning-investment-style-in-a-bear-market%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Michael Zhuang submits: July 2008 marks the start of a bear market after all major market indices have fallen more than 20% from their most recently peaks. This article is part two of my three-part research on bear markets. In part one, I researched how long a bear market lasts....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 08 Aug 2008 02:50:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
	</item>
	<item>
		<title><![CDATA[SoundBite Communications: Time To Sell]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89728-soundbite-communications-time-to-sell%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Chris Fernandez submits: That&#8217;s it, we&#8217;re done.  It&#8217;s time to liquidate your entire position in SoundBite Communications (NASDAQ: SDBT), a leading provider of on-demand customer contact solutions. by Chris Fernandez]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 07:33:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
	</item>
	<item>
		<title><![CDATA[Methode Electronics: Discounted Valuation Ahead of Future Growth]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89717-methode-electronics-discounted-valuation-ahead-of-future-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Robert Maltbie submits:  Methode Electronics MEI ( $11.91) is a manufacturer of electronic components in the midst of transforming from an auto supplier to a broader, product-driven model. Singular Research believes that MEI's discounted valuation offers an attractive entry point ahead of future growth, and is initiating coverage with...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 07:11:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/methode+electronics+inc..html"><![CDATA[Methode Electronics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MEI</category>
		<category domain="tickers">MEI</category>
	</item>
	<item>
		<title><![CDATA[Optimal Group: Divesting Optimal Payments Subsidiary, Growing WowWee]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89716-optimal-group-divesting-optimal-payments-subsidiary-growing-wowwee%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Badger The Lion submits: Optimal Group, Inc. OPMR expects to divest itself of its remaining U.S. Optimal Payment assets within the next 12 months. This means that the company will be focusing primarily on the growth of its WowWee subsidiary.  OPMR management indicated that they expect OPMR to be...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 07:03:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/gadgets.html"><![CDATA[Gadgets]]></category>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
	</item>
	<item>
		<title><![CDATA[China Pharma Holdings? Q2 Shows Moderating Growth]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89662-china-pharma-holdings-q2-shows-moderating-growth%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  China Pharma Holdings, Inc. (CPHI.OB) reported that its Q2 revenues climbed 32% to $11.3 million. Net income was up by 21% at $4 million. While these numbers are moving in the right direction, the Q2 results are less impressive than the 60% revenue growth and 78%...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 02:55:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
	</item>
	<item>
		<title><![CDATA[Marlin Still a ?Wrong Way Corrigan? Company]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89658-marlin-still-a-wrong-way-corrigan-company%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Christopher Menkin submits: In its telephone conference call Tuesday, Marlin MRLN CEO Dan Dyer, Exec. VP George Perose and CFO Lynne Wilson all attributed the two-third down second quarter 2007 compared to 2008 as a result of &#8220;the economy.&#8221; It was $1.7 million compared to $5.178 million. In fact, their...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 02:45:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/marlin+business+services+corp..html"><![CDATA[Marlin Business Services Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRLN</category>
		<category domain="tickers">MRLN</category>
	</item>
	<item>
		<title><![CDATA[Downgrading 51job, Inc. to Sell]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89833-downgrading-51job-inc-to-sell%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Excerpts from Gilford Securities analyst Ashish R. Thadhani's recent note to clients on 51job, Inc. JOBS:  &#8226; &#8226; &#8226; by Ashish R. Thadhani]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 02:06:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
	</item>
	<item>
		<title><![CDATA[NeuroMetrix: Revenues Decline, Prospects Look Bleak]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89626-neurometrix-revenues-decline-prospects-look-bleak%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Douglas Cress submits: NeuroMetrix NURO reported quarterly revenues of $8.5 million on Tuesday, down approximately 26% from the same period in 2007. The company generated a scant $510,000 (or 6% or revenues) from the sale of devices, including NC-stat System and the newer Advance. That could spell trouble for future...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 07 Aug 2008 01:00:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/smallcap.html"><![CDATA[Smallcap]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/neurometrix.html"><![CDATA[NeuroMetrix]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NURO</category>
		<category domain="tickers">NURO</category>
	</item>
</channel>
</rss>
